Pears Health Cyber was founded 10 years ago. The original team counted for only three people. As time went by the team grew rapidly and today there are 88 core employees in the team and other more than 150 contracting external co-operators. At the occasion of the 10th years of existence of PHC we invited our clients to a garden party which took place in a historic garden in the heart of Prague
Â
E-mail marketing is one of the most effective ways of addressing your existing and potential customers. The relatively low cost of e-mail marketing (due to applying economy of scale) is not the only advantage of this marketing channel. The other facts in favour of e-mail marketing include: possibility to call for an immediate response and possibility of a very detailed analysis of respondents’ behavior.
Â
A poll we recently posted on LinkedIn portal showed that sixty percent of pharma marketing professionals believe that pharma companies go centralized in their marketing activities. Fourty percent of them think that it is a trend for traditional marketing as well as eMarketing activities. This can be the result of the current difficult economic situation together with changes in the legal and regulatory systems across the world making it difficult for pharmaceutical companies to communicate with health care professionals. But is it the right answer to all the economic, social and political issues currently putting pressure on all original pharmaceutical companies?
Â
Good question, I think we really lack ROI studies on e-projects. Lots of great stuff is done, but I have the impression we almost never measure the effectiveness...
I am wondering, why so many questions and questionmarks arise around ROI of e-projects. E-projects usually take about 3% of the whole marketing budget in pharma. All the other 97 % are spent and ROI is very rarely measured and questioned in these. Why to bother so much about ROI of e. Should not we start using it and see real resulst and impact in our target audience behaviour?